Show simple item record

Risiko ved covid-19-epidemien, influensa og RSV-infeksjon i Norge. Folkehelseinstituttet 29. juni 2022. Notat.

dc.contributor.authorStoltenberg, Camilla
dc.date.accessioned2022-10-10T06:27:44Z
dc.date.available2022-10-10T06:27:44Z
dc.date.created2022-10-07T10:33:00Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/11250/3024869
dc.language.isonob
dc.publisherFolkehelseinstitutet
dc.relation.urihttps://www.fhi.no/contentassets/c9e459cd7cc24991810a0d28d7803bd0/vedlegg/2022-06-29-risikovurdering-endret-2022-07-01.pdf
dc.subject.meshCovid-19
dc.subject.meshRisk Assessment
dc.subject.meshCoronavirus Infections
dc.subject.meshEpidemics
dc.subject.meshGenetic Variation
dc.subject.meshMutation
dc.subject.meshNorway
dc.subject.meshCoronavirusinfeksjoner
dc.subject.meshEpidemier
dc.subject.meshRisikovurdering
dc.subject.meshGenetisk variasjon
dc.subject.meshGenetisk diversitet
dc.subject.meshNorge
dc.titleRisiko ved covid-19-epidemien, influensa og RSV-infeksjon i Norge. Folkehelseinstituttet 29. juni 2022. Notat.
dc.typeResearch report
dc.description.versionpublishedVersion
dc.source.pagenumber43
dc.identifier.cristin2059472
dc.subject.keywordOmikronvarianten
dc.subject.keywordOmicron Variant
cristin.ispublishedtrue
cristin.fulltextoriginal


Files in this item

Thumbnail
Name:
2022-06-29-risikovurdering-end ...
Size:
3.220Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record